Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS)
CNY 8.03
(0.0%)
CNY 8.03
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 671.62 Million | 654.97 Million | 693.96 Million | 758.13 Million | 681.22 Million | 545.76 Million |
| Cost of Revenue | 240.59 Million | 206.81 Million | 192.6 Million | 194.17 Million | 183.11 Million | 194.82 Million |
| Gross Profit | 431.02 Million | 448.15 Million | 501.36 Million | 563.96 Million | 498.11 Million | 350.94 Million |
| Operating Expenses | 249.26 Million | 312.16 Million | 336.64 Million | 378.82 Million | 341.19 Million | 241.72 Million |
| Selling, General and Administrative Expenses | 137.06 Million | 204.1 Million | 229.33 Million | 292.76 Million | 283.21 Million | 179.85 Million |
| Research and Development Expenses | 47.14 Million | 44.3 Million | 39.71 Million | 31.79 Million | 29.57 Million | 26.26 Million |
| Other Expenses | -45.97 Million | 63.75 Million | 67.6 Million | 54.26 Million | 28.4 Million | 188.38 Thousand |
| Cost and Expenses | 497.71 Million | 518.98 Million | 529.25 Million | 572.99 Million | 524.31 Million | 436.54 Million |
| Operating Income | 173.9 Million | 164.42 Million | 198.53 Million | 190.36 Million | 154.28 Million | 112.7 Million |
| Interest Expense | 15.32 Million | 9.13 Million | 4.52 Million | 4.95 Million | 494.19 Thousand | 731.48 Thousand |
| Income Tax Expense | 12.01 Million | 2.65 Million | 26.27 Million | 23.94 Million | 21.98 Million | 15.49 Million |
| Earnings before Tax | 174.06 Million | 163.84 Million | 197.5 Million | 188.89 Million | 152.94 Million | 112.89 Million |
| Net Income | 162.89 Million | 161.58 Million | 170.79 Million | 165.14 Million | 131.39 Million | 96.91 Million |
| Earnings Per Share Basic | 0.50 | 0.49 | 0.52 | 0.50 | 0.40 | 0.30 |
| Earnings Per Share Diluted | 0.50 | 0.49 | 0.52 | 0.50 | 0.40 | 0.30 |
| Weighted Average Shares Outstanding | 325.79 Million | 327.3 Million | 327.3 Million | 327.3 Million | 327.3 Million | 327.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 325.79 Million | 327.3 Million | 327.3 Million | 327.3 Million | 327.3 Million | 328.3 Million |
| Gross Margin | 0.64 | 0.68 | 0.72 | 0.74 | 0.73 | 0.64 |
| EBIT Margin | 0.40 | 0.38 | 0.38 | 0.34 | 0.27 | 0.25 |
| Profit Margin | 0.24 | 0.25 | 0.25 | 0.22 | 0.19 | 0.18 |
| EBITDA | 267.44 Million | 235.34 Million | 257.06 Million | 241.72 Million | 175.55 Million | 131.07 Million |
| Earnings Before Tax Margin | 0.26 | 0.25 | 0.29 | 0.25 | 0.23 | 0.21 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 160.66 Million | 198.91 Million | 153.05 Million | 671.62 Million | 212.13 Million | 138.62 Million |
| Cost of Revenue | 53.53 Million | 78.88 Million | 45.23 Million | 240.59 Million | 73.95 Million | 51.01 Million |
| Gross Profit | 107.13 Million | 120.02 Million | 107.82 Million | 431.02 Million | 138.18 Million | 87.6 Million |
| Operating Expenses | 83.42 Million | 81.13 Million | 78.02 Million | 294.24 Million | 77.64 Million | 71.22 Million |
| Selling, General and Administrative Expenses | 70.41 Million | 68.79 Million | 65.79 Million | - | -10.52 Million | 96.84 Million |
| Research and Development Expenses | 14.14 Million | 10.32 Million | 11.78 Million | - | 11.74 Million | 12.33 Million |
| Other Expenses | 1.14 Million | -2.01 Million | 146.08 Thousand | 152.94 Thousand | -67.72 Thousand | 35.05 Thousand |
| Cost and Expenses | 136.95 Million | 160.02 Million | 123.25 Million | 534.84 Million | 151.59 Million | 122.24 Million |
| Operating Income | 23.71 Million | 38.88 Million | 37.5 Million | 173.9 Million | 55.07 Million | 25.06 Million |
| Interest Expense | 2.13 Million | 3.27 Million | 3.38 Million | 15.26 Million | 3.73 Million | 3.96 Million |
| Income Tax Expense | 2.44 Million | 5.9 Million | 4.92 Million | 12.01 Million | 6.45 Million | 1.9 Million |
| Earnings before Tax | 31.82 Million | 40.12 Million | 37.65 Million | 174.06 Million | 55 Million | 25.1 Million |
| Net Income | 40.6 Million | 43.78 Million | 32.68 Million | 162.89 Million | 48.94 Million | 23.34 Million |
| Earnings Per Share Basic | 0.12 | 0.13 | 0.10 | - | 0.15 | 0.07 |
| Earnings Per Share Diluted | 0.12 | 0.13 | 0.10 | - | 0.15 | 0.07 |
| Weighted Average Shares Outstanding | 327.3 Million | 327.3 Million | 326.84 Million | 325.79 Million | 326.48 Million | 327.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 327.3 Million | 327.3 Million | 326.84 Million | 325.79 Million | 326.48 Million | 327.3 Million |
| Gross Margin | 0.67 | 0.60 | 0.70 | 0.64 | 0.65 | 0.63 |
| EBIT Margin | 0.21 | 0.32 | 0.28 | - | 0.34 | 0.21 |
| Profit Margin | 0.25 | 0.22 | 0.21 | 0.24 | 0.23 | 0.17 |
| EBITDA | 33.96 Million | 62.83 Million | 42.17 Million | - | 71.18 Million | 29.46 Million |
| Earnings Before Tax Margin | 0.15 | 0.20 | 0.25 | 0.26 | 0.26 | 0.18 |
MUNMF
MRP
HLNFF
605077
BRAU
GGIFF